Marc Wilson's Net Worth
$9.93 Million
Who is Marc Wilson?
Marc Wilson has an estimated net worth of $9.93 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., and Cidara Therapeutics, Inc..
SEC CIK
Marc Wilson's CIK is 0001702265
Past Insider Trading and Trends
2024 was Marc Wilson's most active year for acquiring shares with 6 total transactions. Marc Wilson's most active month to acquire stocks was the month of February. 2024 was Marc Wilson's most active year for disposing of shares, totalling 10 transactions. Marc Wilson's most active month to dispose stocks was the month of May. 2024 saw Marc Wilson paying a total of $1,068,296.80 for 207,185 shares, this is the most they've acquired in one year. In 2024 Marc Wilson cashed out on 183,295 shares for a total of $4,607,375.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$31.58 | -$849,897.60 | 111.09K |
Jul 25
| |||
Form 4
|
—
|
0
|
$37.51 | -$874,500.00 | 111.09K |
Jul 15
| |||
Form 4
|
—
|
0
|
$26.45 | -$1,102,988.57 | 111.09K |
Jun 28
| |||
Form 4
| -8.99% | -10.93K |
$41.17 | -$449,792.84 | 110.63K |
Scheduled
|
Mar 18 - Mar 19
| ||
Form 4
| +26.55% | 25.5K |
—
|
—
| 121.56K |
Mar 4
| |||
Form 4
|
—
|
0
|
$22.38 | -$261,900.00 | 96.06K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$19.02 | -$194,700.00 | 95.6K |
Scheduled
|
Nov 1
| ||
Form 4
| -10.30% | -10.92K |
$14.63 | -$431,803.12 | 95.16K |
Jun 20
| |||
Form 4
| -1.55% | -1.67K |
$17.12 | -$28,521.92 | 106.08K |
Scheduled
|
Mar 16
| ||
Form 4
| +28.97% | 24.2K |
—
|
—
| 107.75K |
Mar 1
| |||
Form 4
| +31.39% | 19.5K |
—
|
—
| 81.62K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $13
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +93.35% | 5K |
—
|
—
| 10.36K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16 - Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||